Last reviewed · How we verify
NCT05204667: MioPain
Different Dosage Regimens of Methocarbamol/Paracetamol in Acute Non-specific Low Back Pain. MioPain Study
Phase 4 trial testing 380 mg/300 mg comprimidos metocarbamol/paracetamol - 4 times daily in Low Back Pain in 172 participants. Terminated before completion.
3 November 2023
Quick facts
| Lead sponsor | Aziende Chimiche Riunite Angelini Francesco S.p.A |
|---|---|
| Phase | Phase 4 |
| Status | Terminated |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 172 |
| Start date | 7 October 2021 |
| Primary completion | 3 November 2023 |
| Estimated completion | 28 February 2024 |
| Sites | 3 locations across Italy |
Drugs / interventions tested
- 380 mg/300 mg comprimidos metocarbamol/paracetamol - 4 times daily — full drug profile →
- 380 mg/300 mg comprimidos metocarbamol/paracetamol - 6 times daily — full drug profile →
Conditions studied
- Low Back Pain — all drugs for Low Back Pain →
Sponsor
Aziende Chimiche Riunite Angelini Francesco S.p.A — full company profile →
Who can join
Adults 18 to 64, any sex, with Low Back Pain. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The aim of the study is to evaluate the efficacy and safety of different dosage regimens of the combination methocarbamol/paracetamol in the treatment of patients with acute non-specific Low Back Pain.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05204667
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Low Back Pain
Currently open trials in the same condition.
- NCT07526012 — Comparative Effects Of Post Isometric Relaxation Versus Active Isolated Stretch In Patients With Piriformis Syndrome · NA · recruiting
- NCT07535047 — Placebo-Induced Hypoalgesia During Transcutaneous Electrical Nerve Stimulation Application in Low Back Pain · NA · recruiting
- NCT07463729 — Evaluation of Stabilization Training With Biofeedback in Lumbosacral Spine Pain Syndrome · NA · recruiting
- NCT07250568 — Office Program Effects on Pain, Posture, Muscle Physiology, Stress, Ergonomics, and Quality of Life in LBP Workers · NA · recruiting
- NCT07467070 — Effectiveness of Pilates on Postural Correction, Core Strength and Flexibility in Younger Individuals With Non-specific · NA · recruiting
Other Aziende Chimiche Riunite Angelini Francesco S.p.A trials
Trials by the same sponsor.
- NCT07199543 — Palatability Study of Five Formulations of Benzydamine HCl Lozenges · Phase 1 · completed
- NCT06922175 — REACH: RWE Retrospective Study to Evaluate Cenobamate Impact on Health Care Resource Utilization · recruiting
- NCT06650631 — The Effectiveness of Heat Treatment on Knee Pain in Patients With Osteoarthritis - an International, Multicenter Clinica · NA · recruiting
- NCT06773767 — Bioavailability of Trazodone Hydrochloride (New Polymer) vs. Trazodone Hydrochloride Contramid® at Steady-state. · Phase 1 · completed
- NCT05867160 — Adjunctive Anti-seizure Medication (ASM) Real World Evidence (RWE) Study · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05204667 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Aziende Chimiche Riunite Angelini Francesco S.p.A
- Last refreshed: 31 January 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05204667.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing